Oncorus Raises $79.5m To Take Its First Oncolytic Virus Into The Clinic

stairs to the big money - Image
Oncolytic virus developer Oncorus closed a series B round. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Financing

More from Business